National Institutes of Health
Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing November 5, 2028.
Nov 5, 2028
(828d left)